On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...